Department of Medicine II, Section Molecular Hepatology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Cell Commun Signal. 2013 Jan 22;11(1):6. doi: 10.1186/1478-811X-11-6.
Dedifferentiation and loss of hepatocyte polarity during primary culture of hepatocytes are major drawbacks for metabolic analyses. As a prominent profibrotic cytokine and potent inducer of epithelial mesenchymal transition (EMT), TGF-β contributes to these processes in liver epithelial cells. Yet, a distinction between culture dependent and TGF-β driven hepatocyte dedifferentiation has not been shown to date.
Here, we show that in both settings, mesenchymal markers are induced. However, upregulation of Snai1 and downregulation of E-Cadherin are restricted to TGF-β effects, neglecting a full EMT of culture dependent hepatocyte dedifferentiation. Mechanistically, the latter is mediated via FAK/Src/ERK/AKT pathways leading to the induction of the oncogene caveolin-1 (Cav1). Cav1 was recently proposed as a new EMT marker, but our results demonstrate Cav1 is not up-regulated in TGF-β mediated hepatocyte EMT, thus limiting validity of its use for this purpose. Importantly, marking differences on Cav1 expression exist in HCC cell lines. Whereas well differentiated HCC cell lines exhibit low and inducible Cav1 protein levels - by TGF-β in a FAK/Src dependent manner, poorly differentiated cell lines display high Cav1 expression levels which are not further modulated by TGF-β.
This study draws a detailed distinction between intrinsic and TGF-β mediated hepatocyte dedifferentiation and elucidates cellular pathways involved. Additionally, by evaluating the regulation of the oncogene Cav1, we provide evidence to argue against Cav1 as a reliable EMT marker.
原代培养的肝细胞发生去分化和失去极性是代谢分析的主要缺点。TGF-β作为一种重要的促纤维化细胞因子和上皮间充质转化(EMT)的有效诱导剂,促进了肝上皮细胞的这些过程。然而,迄今为止,尚未证明细胞培养依赖性和 TGF-β驱动的肝细胞去分化之间存在区别。
在这里,我们表明在这两种情况下,间质标志物均被诱导。然而,Snai1 的上调和 E-钙粘蛋白的下调仅限于 TGF-β的作用,忽略了细胞培养依赖性肝细胞去分化的完全 EMT。从机制上讲,后者是通过 FAK/Src/ERK/AKT 途径介导的,导致致癌基因小窝蛋白-1(Cav1)的诱导。Cav1 最近被提议作为 EMT 的新标志物,但我们的结果表明,Cav1 在 TGF-β介导的肝细胞 EMT 中并未上调,因此限制了其在此目的中的使用的有效性。重要的是,在 HCC 细胞系中 Cav1 表达的标记差异存在。尽管分化良好的 HCC 细胞系表现出低水平和可诱导的 Cav1 蛋白水平-通过 TGF-β以 FAK/Src 依赖性方式,而分化不良的细胞系则表现出高水平的 Cav1 表达,TGF-β不能进一步调节其表达。
本研究详细区分了内在的和 TGF-β 介导的肝细胞去分化,并阐明了所涉及的细胞途径。此外,通过评估致癌基因 Cav1 的调节,我们提供了证据来反对 Cav1 作为可靠的 EMT 标志物。